| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMEA/470632/2009 (23.7.09) |
| Publication Date | 23/07/2009 |
| Content Type | News |
|
Insulin glargine is a long-acting insulin analogue, authorised in the European Union as Lantus and Optisulin, for the treatment of adults, adolescents and children aged six years and above, with diabetes, when treatment with insulin is required. |
|
| Source Link | Link to Main Source http://www.emea.europa.eu/humandocs/PDFs/EPAR/Lantus/47063209en.pdf |
| Subject Categories | Health |
| Countries / Regions | Europe |
